ISSN: 1889-1837

Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

Indexed in:

Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.234

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.46

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Renin–angiotensin–aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial

Efecto de los bloqueantes del sistema renina-angiotensina-aldosterona en la progresión de enfermedad renal crónica en pacientes hipertensos añosos sin proteinuria: ensayo clínico Progresión de Enfermedad Renal Crónica en Ancianos

A.M. García-Prietoa,

Corresponding author

anamgarciaprieto@gmail.com

Corresponding author.